4 weeks Sagimet Biosciences (NASDAQ:SGMT) Receives Buy Rating from HC WainwrightMarketBeat
HC Wainwright reaffirmed a “buy” rating and set a $32.00 target price on shares of Sagimet Biosciences in a research note on Thursday.
XHC Wainwright reaffirmed a “buy” rating and set a $32.00 target price on shares of Sagimet Biosciences in a research note on Thursday.
X